⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for leukemia, chronic lymphocytic

Every month we try and update this database with for leukemia, chronic lymphocytic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLLNCT02973399
Cancer
SNX-5422 plus i...
18 Years - Esanex Inc.
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLLNCT02973399
Cancer
SNX-5422 plus i...
18 Years - Esanex Inc.
Safety and Activity of SNX-5422 Plus Ibrutinib in CLLNCT02914327
Cancer
SNX-5422 plus i...
18 Years - Esanex Inc.
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010)NCT05947851
Leukemia, Lymph...
Leukemia, Chron...
Small-Cell Lymp...
Lymphoma, Small...
CLL
SLL
Nemtabrutinib
Venetoclax
Rituximab
18 Years - Merck Sharp & Dohme LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: